Highlights

  • Strong shareholder participation with ~80.9% take-up rate
  • NZ$242.7 million raised from eligible investors, including Crown support
  • Remaining shares to be allocated through shortfall bookbuild

Genesis Energy Limited (NZX:GNE) has successfully completed its NZ$300 million pro rata renounceable rights offer, receiving strong backing from shareholders. The offer achieved an 80.9% take-up rate, with NZ$242.7 million in applications, including continued participation from the Crown, which retains its 51% stake. Additional applications worth NZ$48.1 million were submitted for extra shares, to be considered in the shortfall bookbuild. The capital raise reflects investor confidence in Genesis’ long-term Gen35 strategy. Settlement and trading of new shares are scheduled for late March 2026, with all new shares ranking equally with existing ones.

Strong Shareholder Support

The rights offer saw significant engagement from eligible shareholders, demonstrating confidence in Genesis Energy’s future growth plans. A total of NZ$242.7 million was raised through shareholder participation, representing a robust take-up rate of 80.9%. Notably, the Crown maintained its majority ownership of 51%, reinforcing its ongoing commitment to the company. Shareholders who fully exercised their entitlements also applied for additional shares worth NZ$48.1 million, indicating excess demand. This level of participation highlights strong investor alignment with Genesis’ Gen35 strategy, which focuses on transitioning toward sustainable energy and long-term value creation for stakeholders.

Shortfall Bookbuild and Next Steps

Following the completion of the rights offer, approximately 27.9 million shares remain available and will be distributed through a shortfall bookbuild managed by Jarden Securities Limited. Investors who did not fully participate, as well as ineligible shareholders, may benefit from any premium achieved above the issue price of NZ$2.05, although such gains are not guaranteed. Applicants for additional shares may receive allocations at the final bookbuild price, subject to scaling. Settlement is expected on 24 March 2026 for ASX and 25 March for NZX, with trading of new shares commencing shortly after.

FAQs

  1. What was the size of the rights offer?

The rights offer was valued at NZ$300 million.

  1. What was the shareholder participation rate?

Approximately 80.9% of eligible shareholders took part.

  1. What happens to the remaining shares?

They will be allocated through a shortfall bookbuild process.